In this issue:
RACGP guidelines for preventive activities in general practice
Management of adverse events from PARP inhibitor + novel hormonal combo therapy
Consensus recommendations from the US Prostate Cancer Conference 2024
PBS listings
Talazoparib + enzalutamide listed for BRAC1/2 mutated mCRPC
Flow-on changes to co-dependent pathology services
Novartis sues to stop compounded 177Lu PSMA therapy
PBAC recommendations
MBS items under consideration
Acute radiotherapy toxicity elevates risk of later toxicity
UK Man Van effectively screens for prostate cancer in underserved populations
PSA screening recommendations impact prostate cancer incidence
COVID-19 resources
Conferences & Workshops
Please login below to download this issue (PDF)